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Purpose: Polymorphisms of several candidate genes have been studied and associ-
ated with the development of chronic obstructive pulmonary disease (COPD). One 
such candidate is the SERPINE2 (Serpin peptidase inhibitor, clade E member 2) 
gene. Materials and Methods: To assess whether the SERPINE2 gene is associat-
ed with COPD in a Chinese Han population. Samples were collected from a Chi-
nese Han population and analyzed for the association of single nucleotide polymor 
phisms (SNPs) or haplotypes of SERPINE2 gene with COPD in a case-control 
study. Three SNPs including rs840088 G/A in intron 1, rs1438831 A/G in 5’ up-
stream sequence and rs3795879 G/A in intron 3 were detected using the poly-
merase chain reaction (PCR)-based restriction fragment length polymorphism   
technique in 409 COPD subjects and 411 controls. Genotyping of the SREPINE2 
polymorphisms at positions rs840088, rs1438831and rs3795879 was performed. 
Results: We found that none of the rs840088G/A, rs1438831G/A and rs3795879 
G/A polymorphisms were associated with the disease. The p-values were 0.630, 
0.208 and 0.398 respectively. Conclusion: Our data suggested that there was no 
significant association between SERPINE2 polymorphism and COPD susceptibility 
in the Chinese Han population.
Key Words:    Chronic obstructive pulmonary disease, SERPINE2 gene, polymor-
phism, susceptibility
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is characterized by irreversible 
and progressive bronchial obstruction and persistent airway inflammation. It is a 
common, complex disease that causes severe morbidity and mortality.1 It is the 
fourth leading cause of death in the world,2 and its prevalence and mortality are 
expected to be increased in the coming decades.3 Therefore, a clear understanding 
of the various aspects of susceptibility to this lung disease is necessary in order to 
develop better treatments. Aihua Wang, et al.
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of COPD according to the ATS with post-bronchodilator 
FEV1/FVC <70%. We also excluded patients with bronchi-
al asthma, bronchiectasis, interstitial pulmonary disease, tu-
berculosis and pulmonary tumors. The control group was 
made up of healthy individuals who were admitted for an 
annual checkup. The criteria for control subjects included: 
age >40 years, with post-bronchodilator FEV1 >80% pre-
dicted and FEV1/FVC >70%, with no respiratory symptoms 
and normal manifestation on chest X-ray (CXR).
Patients
All study subjects involved in this investigation were recruit-
ed upon giving informed consent. The study design was ap-
proved by the ethical committee of Shandong University. 
This prospective observational study involved 409 patients 
with clinical diagnosis of COPD and 411 unrelated healthy 
controls without any respiratory system diseases. These 820 
selected participants were of the Chinese Han population. 
All the patients and case-controls were recruited from Qilu 
Hospital and the Second Affiliated Hospital of Shandong 
University of Traditional Chinese Medicine. The average 
ages of the COPD patients and case-controls were 65.1 
years and 63.7 years, respectively.
Specimens
Blood samples were drawn from the antecubital vein and 
stored at 4°C before genomic DNA was isolated.
DNA preparation
Genomic DNA was extracted from leucocytes of 2 mL pe-
ripheral blood using a standardized method.17 The DNA con-
centration and purity of each sample were analyzed by ul-
traviolet spectrophotometry. All DNA samples were stored at 
-20°C until analysis.
PCR-RFLP (PCR-restriction fragment length 
polymorphism)
In order to detect the polymorphism of the SERPINE2 gene 
in COPD, we performed a restriction fragment length poly-
morphism analysis. In brief, primers were designed accord-
ing to the published sequence (Gene Bank: NC_000002.10). 
The forward and reverse primers for the amplifications of 
rs840088 (304bp), rs1438831 (402bp) and 3795879 (194bp) 
were: 5’-TACACTGGAGGTAGGTTGCC-3’ and ‘5-CCT 
TTAGAGTCAGGGATTT-3’; 5’-TGGGTCATTACT 
TCTCTC-3’ and ‘5-ATAGGGTCCAAATTCTTC-3’; 
5’-TTGAAGTGCCTTTTGTTAC-3’ and ‘5-TTGAACC 
So far, cigarette smoking has been proven the most im-
portant risk factor for COPD. Alpha 1-antitrypsin (AAT) 
deficiency is another proven genetic risk factor for COPD. 
However, only 15% of smokers have this disease and AAT 
deficiency is present in only 1-2% of COPD cases.4 Fur-
thermore, nonsmokers may also develop chronic airflow 
obstruction.5,6 All of these data suggest that genetic consti-
tution as well as living habits play a role in the develop-
ment and severity of COPD.7,8 Several studies have sug-
gested that other genetic factors may also be involved in the 
patheogensis of COPD. Polymorphisms of several candi-
date genes have been studied and associated with the devel-
opment of COPD.9 One such candidate is the SERPINE2 
[Serpin peptidase inhibitor, clade E (nexin, plasminogen ac-
tivator inhibitor type 1), member 2] gene. Genetic associa-
tions with COPD-related traits can help to define distinct 
subtypes of COPD.10-12
SERPINE2 is located on chromosome 2q33-35. Using 
gene-expression microarray and animal model experiments, 
DeMeo and colleagues identified SERPINE2 as a novel 
COPD-susceptibility gene.13 Zhu and colleagues also con-
firmed the association between SERPINE2 and COPD in a 
large case-control collection from Bergen, Norway, which 
included 973 cases with COPD and 956 control subjects.14 
However, Chappell and colleagues’ prospective study of 
1,018 COPD cases and 911 controls coming from six Euro-
pean centers suggested that there was no significant associ-
ation between SERPINE2 and COPD.15 In order to clarify 
these contradictory results of SERPINE2 in COPD, we con-
ducted a case-control association study of three known sin-
gle nucleotide polymorphisms (SNPs) of the SERPINE2 
gene in the Chinese population.
MATERIALS AND METHODS
　　　
Diagnosis
COPD was diagnosed on the basis of medical history, chest 
radiographic findings, physical examination and spiromet-
ric data, according to a definition of COPD which was con-
sistent with that of the American Thoracic Society (ATS) 
consensus statement.16 Pulmonary function is critical to iden-
tifying whether COPD exists. We performed pulmonary 
function tests (Jaeger Master Screen Diffusion, Germany) 
to determine FVC, FEV1, FEV1% predicted, FEV1/FVC 
and post-bronchodilator FEV1/FVC. The inclusion criteria 
for COPD patients were based on the diagnosis standards SERPINE2 Gene and COPD in Chinese Han
Yonsei Med J   http://www.eymj.org   Volume 52   Number 6   November 2011 955
rs3795879 G/A allele, the cleavage products of 134 bp and 
60 bp were obtained when G allele was present.
DNA sequencing
Direct sequencing of a subgroup of samples with the same 
primers was used to further validate the authenticity of geno-
type analysis. Sequencing was performed using the BigDye 
Terminator v1.1 Cycle Sequencing kit (Applied Biosystems), 
and analyzed on an ABI PRISM 3100 DNA sequencer (Ap-
plied Biosystems, Foster City, CA, USA).
Statistical analysis
Patient and case-control age is expressed as mean±SD. We 
evaluated each variation for deviations from Hardy-Wein-
berg equilibrium (HWE) by means of χ2 test. The genotype 
distributions and allelic frequencies for studied polymor-
phisms of the COPD patients and control-group individuals 
were statistically compared using the χ2 test as well as SPSS 
software for Windows (version 13.0; SPSS Inc., Chicago, 
IL, USA). The haplotype distributions between patients and 
control groups were assessed by the Monte Carlo method 
using shesis. A p-value of less than 0.05 was considered to 
indicate statistical significance.
RESULTS
 　
Clinical characteristics
A total of 820 subjects, including 409 COPD patients and 
411 healthy controls, were studied. The demographic char-
acteristics and relevant clinical parameters of all patients 
and controls are showed in Table 1. The average age of the 
COPD patients, consisting of 251 men and 158 women, 
CTGGAGTCTAAC-3’, respectively. A total of 50 ng ge-
nomic DNA was mixed in a total volume of 25 μL contain-
ing 1.0 U Taq DNA polymerase, 200 μmol/L each dNTP 
(mixture of dATP dTTP dCTP dGTP), 10 mmol/L Tris-HCL 
(PH 8.3), 1.5 mmol/L MgCL2, 0.2 μmol/L of each primer 
(previously described). Amplification was performed with 
an initial denaturation step at 94°C for 5 min followed by 
35 cycles of denaturation at 94°C for 40 s each, annealing 
at optimum temperature for 40 s, and extension at 72°C for 
60 s. A final extension was carried out at 72°C for 10 min. 
The optimal annealing temperatures for the three SNPs 
were: 54°C for rs840088, 55°C for rs143883, and 50°C for 
rs3795879 respectively. PCR amplification was performed 
in a programmable PCR thermal cycler (GeneAmp PCR 
System 2400, Perkin-Elmer, Wellesley, MA, USA). 10 μL 
of PCR product was used for electrophoresis on 2.0% aga-
rose gels stained with ethidium bromide. The gels were vi-
sualized and photographed using an ultraviolet light transil-
luminator.
For genotyping the polymorphism of SNPs rs840088, 
rs1438831, rs3795879, the PCR products were digested with 
MLY1, Taq1, MSC1 (Gene corporation, Shanghai, China) 
for 3 h at 37°C, 3 h at 65°C, or 3 h at 37°C, respectively, ac-
cording to the product’s instructions. After electrophoresis 
in 2.0% agarose gel and staining with ethidium bromide, 
the genotypes were determined.
The possible outcomes were: the rs840088G/A allele was 
genotyped by PCR-RFLP. MLY1 digestion cleaved the 304 
bp PCR products into two fragments of 177 bp and 127 bp 
when the G allele was present; The SNP rs1438831G/A was 
also analyzed by RFLP using Taq1 enzyme. Taq1 digestion 
cut the 402 bp PCR products into two fragments of 292 bp 
and 110 bp when the G allele was present; In the case of the 
Table 1. Clinical Features of the Study Population*  
Characteristics Patients Controls p value
†
Total number 409 411
Gender (Male/Female) 251/158   266/145   0.84
Age (yrs) 65.14±11.82   63.70±10.51 0.07
Smoking status (smoker/nonsmoker) 219/190 223/188 0.32
FEV1, (L) 1.44±0.63   2.55±0.69 <0.001
FEV1% pred 56.69±21.45 102.02±14.33 <0.001
FEV1/FVC, % 52.80±12.07 79.84±5.75 <0.001
COPD, chronic obstructive pulmonary disease.
Four hundred and nine patients with clinical diagnosis of COPD and 411 unrelated healthy controls without any respiratory system dis-
eases, all of Chinese Han nationality, were selected for study. COPD was diagnosed according to the guidelines of the American Tho-
racic Society (ATS) consensus statement. Pulmonary function tests were performed to determine FVC, FEV1, FEV1% predicted, FEV1/
FVC and post-bronchodilator FEV1/FVC.
*Data are presented as No. or mean SD. 
†p values were calculated using the Mann  -Whitney U-test.Aihua Wang, et al.
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controls. The frequency of homozygote AG was 22.7% in 
COPD and 24.6% in the controls, and the frequency of ho-
mozygote GG genotype was 1.7% in the cases and 2.9% in 
controls. The frequencies of genotypes rs1438831 in pa-
tients were also not significantly different from those of 
controls (p=0.208). Moreover, we found no association with 
rs3795879 (p=0.398).
The allele frequencies of SERPINE2
The SERPINE2 genotypes and allele frequencies for the 
two groups are shown in Table 3; The χ2 test showed that 
the patient group did not have a significantly higher fre-
quency than the control group of rs840088 G/A alleles, 
rs1438831 G/A alleles and rs3795879 G/A alleles (p=0.567, 
p=0.960 and p=0.217, respectively).
Haplotype analysis
Three SNPs were used to construct haplotypes. Using SHE-
sis software, we constructed four haplotypes (frequency 
>0.05). Their frequencies are listed in Table 4. There was no 
significant association in terms of haplotype frequencies of 
the four haplotypes in COPD patients and controls (p>0.05).
Verification of SERPINE2 genotypes
In this study, the polymorphism analysis of SERPINE2 was 
performed by PCR-RFLP, and the representative data are 
shown in Fig. 1, Fig. 2, and Fig. 3. As for rs840088, the AA 
was 65.1 years old, compared with 63.7 years of the con-
trols, consisting of 266 men and 145 women. No significant 
differences in sex, age or smoking history were observed be-
tween the COPD cases and controls. The parameters of 
FEV1, FVC, FEV1% predicted and FEV1/FVC were signif-
icantly lower in COPD patients than the controls (p<0.001).
Distributions of rs840088, rs1438831, rs3795879 
genotypes
The genotype distributions of rs840088, rs1438831, rs3795879 
among the controls and the COPD patients are shown in 
Table 2. There was no significant deviation in the genotype 
frequency from the Hardy-Weinberg equilibrium (p>0.05). 
For rs840088, the frequency of the homozygote AA geno-
type was 13.9% in COPD and 16.3% in controls, the fre-
quency of homozygote AG was 51.6% in the cases and 
49.6% in the controls, the frequency of homozygote GG 
genotype was 34.5% in the cases and 34.1% in the controls. 
The frequencies of genotypes rs840088 AA, AG, GG in 
cases were not significantly different from those of the con-
trols (p=0.630). Besides, for rs1438831, the frequency of ho-
mozygote AA genotype was 2.9% in COPD and 4.9% in the 
controls. The frequency of homozygote AG was 30.6% in 
the controls and 34.7% in the cases; the frequency of ho-
mozygote GG genotype was 62.4% in the cases and 64.5% 
in the controls. For rs3795879, the frequency of homozy-
gote AA genotype was 75.6% in COPD and 72.5% in the 
Table 2. Genotype Frequencies of SERPINE2 between COPD Patients and Controls, and Corresponding ORs 
for COPD  
Genotype
COPD patients 
n=409 (%)
Controls 
n=411 (%)
p value*
Odds ratio
(95% CI)
‡
rs840088 0.630
    G/G 141 (34.5) 140 (34.1) 1.000
    A/A    57 (13.9)
†   67 (16.3) 0.993 (0.702, 1.404)
    G/A 211 (51.6) 204 (49.6) 0.880 (0.530, 1.461)
rs1438831 0.208
    G/G 255 (62.4) 265 (64.5) 1.000
    A/A 12 (2.9) 20 (4.9) 1.499 (1.009, 2.225)
    G/A 142 (34.7) 126 (30.6) 0.870 (0.331, 2.284)
rs3795879 0.398
    A/A 309 (75.6) 298 (72.5) 1.000
    G/A   93 (22.7) 101 (24.6) 0.740 (0.492, 1.113)
    G/G   7 (1.7) 12 (2.9) 0.709 (0.225, 2.236)
The genotype distributions of rs840088, rs1438831, rs3795879 in controls and COPD patients were calculated. Each variation for devia-
tions from Hardy  -Weinberg equilibrium (HWE) was evaluated by means of an χ
2 test.
COPD, chronic obstructive pulmonary disease.
*p values were calculated using the χ
2 test. 
†Data are presented as No. (%). 
‡Odds ratios were calculated using logistic regression to measure the ORs for COPD of specific genotypes.SERPINE2 Gene and COPD in Chinese Han
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Table 3. Allelic Frequencies of SERPINE2 between COPD Patients and Controls, and Corresponding ORs for COPD 
Allelic frequency
COPD patients
n=818 (%)
Controls
n=822 (%)
p value*
rs840088 0.567
    Allele A 325 (39.7)
† 338 (41.2)
    Allele G   493 (60.3） 484 (58.8)
rs1438831 0.960
    Allele A 166 (20.3) 166 (20.2)
    Allele G 652 (79.7) 656 (79.8)
rs3795879 0.217
    Allele A 711 (86.9) 697 (84.8)
    Allele G 107 (13.1) 125 (15.2)
The SERPINE2 genotypes and allele frequencies for the two groups were statistically compared using the χ
2 test. 
COPD, chronic obstructive pulmonary disease.
*p-values were calculated using the χ
2 test.
†Data are presented as No. (%). 
Table 4. The Haplotype Frequencies of Three Single Nucleotide Polymorphisms of SERPINE2 in COPD Patients 
and Controls 
Haplotype rs840088 rs1438831 rs3795879
Haplotype frequency
χ
2 (global p value)*
Control COPD
Hap1 A G G 0.557 0.572 0.996
Hap2 A A G 0.207 0.205
Hap3 G A A 0.112 0.109
Hap4 A A A 0.076 0.078
Three SNPs were used to construct haplotypes. Using SHEsis software, four haplotypes were constructed (frequency >0.05). There is no 
significant association of haplotype frequencies of four haplotypes with COPD patients and controls (p>0.05).
SNPs, single nucleotide polymorphisms; COPD, chronic obstructive pulmonary disease.
*The global p-value was calculated with haplotype frequencies greater than 0.03 by the online software. 
Fig. 1. The genotype analysis of SNP rs840088 by the PCR-restriction frag-
ment length polymorphism (PCR-RFLP) method. rs840088G/A allele was 
genotyped by PCR-RFLP. PCR products were digested with MLY1 for 3 h at 
37ºC. After electrophoresis in 2.0% agarose gel and staining with ethidium 
bromide, the genotypes were determined. When the GG allele was pres-
ent, MLY1 would cut the 304 bp PCR products into two fragments of 177 bp 
and 127 bp. The AA homozygous case showed a 304 p uncleavage prod-
uct, while the GA heterozygous case showed 304 bp, 177 bp and 127 bp 
products. Lane M: DNA Marker; Lane1, 2, 4, 6: GG genotype; Lane3, 7, 8: GA 
genotype; Lane5: AA genotype. 90×66 mm (300×300 DPI). SNP, single nucle-
otide polymorphism.
Fig. 2. The genotype analysis of SNP rs1438831 by the PCR-RFLP method. 
The SNP rs1438831G/A was also analyzed by PCR-RFLP using Taq1 en-
zyme. Taq1 digestion for 3 h at 65ºC cut the 402 bp PCR products into two 
fragments of 292 bp and 110 bp when the GG allele was present. The AA 
homozygous case showed 402 bp uncleavage product, while the GA het-
erozygous case showed 402 bp, 292 bp and 110 bp products. Lane M indi-
cates the 100-bp molecular markers. Lanes 2, 3 and 6 indicate three kinds 
of genotypes: GG, GA, AA respectively. 81×58 mm (300×300 DPI). PCR-RFLP, 
PCR-restriction fragment length polymorphism; SNP, single nucleotide 
polymorphism.
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homozygous case showed a 304 p uncleavage product, the 
GG homozygous case showed 177 bp and 127 bp while the 
GA heterozygous case showed 304 bp, 177 bp and 127 bp 
cleavage products (Fig. 1). As for rs1438831, the AA ho-
mozygous case showed 402 bp uncleavage product, the GG 
homozygous case showed 292 bp and 110 bp, while the GA 
heterozygous case showed 402 bp, 292 bp and 110 bp cleav-
age products (Fig. 2). As for rs3795879, the AA homozygous 
case showed 194 bp uncleavage product, the GG homozy-
gous case showed 134 bp and 60 bp, while the GA hetero-
zygous case showed 194 bp, 134 bp and 60 bp cleavage 
products (Fig. 3).
The DNA sequencing results of the three genotypes of 
SERPINE2 further validated the aforementioned results of 
the PCR-RFLP (Figs. 4, 5 and 6).
DISCUSSION
   
At present, most studies of the pathogenesis of COPD have 
concentrated on the association analysis of candidate genes. 
It is believed that COPD is most likely a polygenic disorder 
with considerable genetic heterogeneity.18 As a way of gain-
ing insight into the possible role of genetic factors in the 
pathogenesis of COPD, we investigated the polymorphisms 
of SERPINE2 gene in a Chinese population.
The SERPINE2 gene belongs to the serpin family of pro-
teins as well as α1-antitrypsin. It is composed of nine ex-
ons, which encode a 44-kD protein that is a thrombin, plas-
min and urokinase inhibitor and plays an important role as 
a cellular regulatory inhibitor of serine protease, mainly in-
volved in coagulation and fibrinolysis and extracellular ma-
trix-associated and mitosis.19 SERPINE2 also prohibits neu-
ron apoptosis and injury-mediated cell death.20 In addition, 
tumor necrosis factor (TNF)-α, IL-1β, and transforming 
growth factor-β can induce expression of SERPINE2.21 As 
SERPINE2 and α1-antitrypsin are from the same family 
and α1-antitrypsin is associated with COPD, it is interesting 
to dissect the role of SERPINE2 in the pathogenesis of 
COPD.
However, its role in the development of COPD is still un-
clear. DeMeo and associates observed that SERPINE2 was 
highly expressed in embryonic mouse lungs as well as in 
airway epithelial cells and vascular adventitia of adult hu-
man lungs. In addition, they suggest that the overexpression 
of SERPINE2 is associated with COPD.13 Other studies 
have confirmed the findings of DeMeo and colleagues. Zhu 
Fig. 3. The genotype analysis of rs3795879 by the PCR-RFLP method. In the 
case of rs3795879, MSC1 cleaved PCR products into 134 bp and 60 bp when 
GG allele was present. AA homozygous case showed 194 bp uncleavage 
product, while the GA heterozygous case showed 194 bp, 134 bp and 60 bp 
products. Lane M was loaded with 100-bp molecular markers. Lanes 1, 2 and 
6 indicate three kinds of genotypes: GA, AA, GG respectively. 81×60 mm 
(300×300 DPI). PCR-RFLP, PCR-restriction fragment length polymorphism.
Fig. 4. The DNA sequencing of rs840088. Direct sequencing of a subgroup 
of samples with the same primers for PCR-RFLP was performed using the 
BigDye Terminator v1.1 Cycle Sequencing kit (Applied Biosystems), and an-
alyzed on an ABI PRISM 3100 DNA sequencer (Applied Biosystems, Foster 
City, USA). (A) GG genotype. (B) GA genotype. (C) AA genotype. 82×48 mm 
(300×300 DPI).
Fig. 5. The DNA sequencing of rs1438831. DNA sequencing was performed 
as described in Fig. 4. (A) GG genotype. (B) GA genotype. (C) AA genotype. 
82×48 mm (300×300 DPI).
Fig. 6. The DNA sequencing of rs3795879. DNA sequencing was performed 
as described in Fig. 4. (A) GG genotype. (B) GA genotype. (C) AA genotype. 
82×48 mm (300×300 DPI).
200 194
134
60
bp
1 2 3 4 5 6 7 8 M
bp
300
400
500
600
100
CCTTCTGACTC
CCTTCGACACT
CCCGCAGTAT
CCTTCTAACTCT
CCTTCAACACT
GCCACAGTAT
CTTCTGACTC
CTTCAACACT
GGCCACAGTA
A
A
A
B
B
B
C
C
CSERPINE2 Gene and COPD in Chinese Han
Yonsei Med J   http://www.eymj.org   Volume 52   Number 6   November 2011 959
REFERENCES
1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; 
GOLD Scientific Committee. Global strategy for the diagnosis, 
management, and prevention of chronic obstructive pulmonary 
disease. NHLBI/WHO Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) Workshop summary. Am J Respir Crit 
Care Med 2001;163:1256-76. 
2. World Health Report. Geneva: World Health Organization. Avail-
able from URL: http://www.who.int/research/en/
3. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, 
et al. Chronic obstructive pulmonary disease: current burden and 
future projections. Eur Respir J 2006;27:397-412. 
4. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 
965 COPD patients. Chest 1986;89:370-3. 
5. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction 
in never smokers: results from the Third National Health and Nu-
trition Examination Survey. Am J Med 2005;118:1364-72. 
6. Behrendt CE. Mild and moderate-to-severe COPD in nonsmok-
ers: distinct demographic profiles. Chest 2005;128:1239-44. 
7. Sandford AJ, Silverman EK. Chronic obstructive pulmonary dis-
ease. 1: susceptibility factors for COPD the genotype-environment 
interaction. Thorax 2002;57:736-41. 
8. Sandford AJ, Joos L, Paré PD. Genetic risk factors for chronic ob-
structive pulmonary disease. Curr Opin Pulm Med 2002;8:87-94. 
9. Molfino NA. Current thinking on genetics of chronic obstructive 
pulmonary disease. Curr Opin Pulm Med 2007;13:107-13. 
10. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet 
AS, et al. Polymorphism of the serotonin transporter gene and 
pulmonary hypertension in chronic obstructive pulmonary disease. 
Circulation 2003;108:1839-44. 
11. Yildiz P, Oflaz H, Cine N, Erginel-Unaltuna N, Erzengin F, Yilmaz 
V. Gene polymorphisms of endothelial nitric oxide synthase enzyme 
associated with pulmonary hypertension in patients with COPD. 
Respir Med 2003;97:1282-8. 
12. Castaldi PJ, Hersh CP, Reilly JJ, Silverman EK. Genetic associa-
tions with hypoxemia and pulmonary arterial pressure in COPD. 
Chest 2009;135:737-44. 
13. Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Cele-
don JC, et al. The SERPINE2 gene is associated with chronic ob-
structive pulmonary disease. Am J Hum Genet 2006;78:253-64. 
14. Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, 
et al. The SERPINE2 gene is associated with chronic obstructive 
pulmonary disease in two large populations. Am J Respir Crit 
Care Med 2007;176:167-73. 
15. Chappell S, Daly L, Morgan K, Baranes TG, Roca J, Rabinovich 
R, et al. The SERPINE2 gene and chronic obstructive pulmonary 
disease. Am J Hum Genet 2006;79:184-6; author reply 186-7. 
16. Standards for the diagnosis and care of patients with chronic ob-
structive pulmonary disease. American Thoracic Society. Am J 
Respir Crit Care Med 1995;152:S77-121. 
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure 
for extracting DNA from human nucleated cells. Nucleic Acids 
Res 1988;16:1215. 
18. Smith OO, Helms PJ. Genetic/environmental determinants of 
adult chronic obstructive pulmonary disease and possible links 
with childhood wheezing. Paediatr Respir Rev 2001;2:178-83. 
19. Carter RE, Cerosaletti KM, Burkin DJ, Fournier RE, Jones C, 
Greenberg BD, et al. The gene for the serpin thrombin inhibitor 
and colleagues genotyped 25 sSNPs from SERPINE2 and 
analyzed qualitative and quantitative COPD phenotypes in 
two large populations. Six SNPs were found to have signif-
icant associations with COPD in the family-based associa-
tion analysis (0.0016≤p≤0.042). Five of these SNPs were 
demonstrated to be replicated associations in the case-con-
trol analysis (0.021≤ p≤0.031).14
The three SNPs in this study were rs840088 G/A in intron 
1, rs1438831 A/G in 5’ upstream sequence, and rs3795879 
G/A in intron 3. Their polymorphisms in the 409 patients 
with COPD and the 411 unrelated controls obtained from a 
Chinese Han population were analyzed. These SNPs have 
been reported to have a role in defining susceptibility phe-
notypes of COPD by influencing inflammatory responses 
to environmental exposure.13 The results of our study 
showed that there was no association between the three 
SNPs in SERPINE2 and COPD in a Chinese population, 
consistent with those of Chappell and colleagues’ study.15 
The reason for this may be complicated. First, association 
studies offer a potentially powerful approach to identify 
genetic variants that influence susceptibility to common 
disease, but are plagued by the impression that the results 
are not consistently reproducible.22 Second, as in many 
complex-disease genetic association studies, and particu-
larly in previous COPD genetic association studies, the re-
sults are inconsistent.23 Third, different populations and 
different levels of environmental exposure may induce dif-
ferent results. Thus, it is possible that different SNPs of 
SERPINE2 contribute to COPD in different ethnic popula-
tions. All of these inconsistent results can induce false-pos-
itive and/or false-negative results.24 It is certain that more 
SNPs of SERPINE2 genes will be identified with advances 
in SNP genotyping, which will allow us to clarify the de-
tails of the functional relationship between SERPINE2 and 
COPD in the future.
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